Increased detection in Australia and Singapore of a novel influenza A(H1N1)2009 variant with reduced oseltamivir and zanamivir sensitivity due to a S247N neuraminidase mutation

Euro Surveill. 2011 Jun 9;16(23):19884.

Abstract

A novel influenza A(H1N1)2009 variant with mildly reduced oseltamivir and zanamivir sensitivity has been detected in more than 10% of community specimens in Singapore and more than 30% of samples from northern Australia during the early months of 2011. The variant, which has also been detected in other regions of the Asia-Pacific, contains a S247N neuraminidase mutation. When combined with the H275Y mutation, as detected in an oseltamivir-treated patient, the dual S247N+H275Y mutant had extremely high oseltamivir resistance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / therapeutic use
  • Australia / epidemiology
  • Drug Resistance / genetics
  • Genetic Predisposition to Disease / epidemiology
  • Genetic Predisposition to Disease / genetics
  • Genetic Variation / genetics
  • Humans
  • Incidence
  • Influenza A Virus, H1N1 Subtype / genetics*
  • Influenza, Human / drug therapy
  • Influenza, Human / epidemiology*
  • Influenza, Human / genetics*
  • Neuraminidase / antagonists & inhibitors
  • Neuraminidase / genetics*
  • Oseltamivir / therapeutic use*
  • Polymorphism, Single Nucleotide / genetics*
  • Population Surveillance / methods
  • Risk Assessment
  • Risk Factors
  • Singapore / epidemiology
  • Zanamivir / therapeutic use*

Substances

  • Antiviral Agents
  • Oseltamivir
  • Neuraminidase
  • Zanamivir